BillionToOne, Inc. (BLLN) has a MoatMap StockRank of 18/100 based on Quality (61/100), Value (10/100), and Momentum (37/100) factor scores. The current signal is STRONG SELL. BillionToOne, Inc. (US, Healthcare) is a small-cap biotech, highly speculative and dependent on specific drug development, not macro themes. It lacks the characteristics of a quality compounder with an uncopyable moat based on broad economic trends.